1 Market Overview

1.1 Product Overview and Scope of Lung Cancer Liquid Biops

1.2 Classification of Lung Cancer Liquid Biops by Type

1.2.1 Overview: Global Lung Cancer Liquid Biops Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Lung Cancer Liquid Biops Revenue Market Share by Type in 2020

1.2.3 Exosomes and RNA

1.2.4 CTCs and ctDNA

1.3 Global Lung Cancer Liquid Biops Market by Application

1.3.1 Overview: Global Lung Cancer Liquid Biops Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Hospitals and Clinics

1.3.3 Physicians'office Laboratories

1.3.4 Clinical Diagnostic Laboratories

1.4 Global Lung Cancer Liquid Biops Market Size & Forecast

1.5 Global Lung Cancer Liquid Biops Market Size and Forecast by Region

1.5.1 Global Lung Cancer Liquid Biops Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Lung Cancer Liquid Biops Market Size by Region, (2016-2021)

1.5.3 North America Lung Cancer Liquid Biops Market Size and Prospect (2016-2026)

1.5.4 Europe Lung Cancer Liquid Biops Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Lung Cancer Liquid Biops Market Size and Prospect (2016-2026)

1.5.6 South America Lung Cancer Liquid Biops Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Lung Cancer Liquid Biops Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Lung Cancer Liquid Biops Market Drivers

1.6.2 Lung Cancer Liquid Biops Market Restraints

1.6.3 Lung Cancer Liquid Biops Trends Analysis

2 Company Profiles

2.1 Biocept

2.1.1 Biocept Details

2.1.2 Biocept Major Business

2.1.3 Biocept Lung Cancer Liquid Biops Product and Solutions

2.1.4 Biocept Lung Cancer Liquid Biops Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Biocept Recent Developments and Future Plans

2.2 EntroGen

2.2.1 EntroGen Details

2.2.2 EntroGen Major Business

2.2.3 EntroGen Lung Cancer Liquid Biops Product and Solutions

2.2.4 EntroGen Lung Cancer Liquid Biops Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 EntroGen Recent Developments and Future Plans

2.3 Cynvenio Biosystems

2.3.1 Cynvenio Biosystems Details

2.3.2 Cynvenio Biosystems Major Business

2.3.3 Cynvenio Biosystems Lung Cancer Liquid Biops Product and Solutions

2.3.4 Cynvenio Biosystems Lung Cancer Liquid Biops Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Cynvenio Biosystems Recent Developments and Future Plans

2.4 Exosome Diagnostics

2.4.1 Exosome Diagnostics Details

2.4.2 Exosome Diagnostics Major Business

2.4.3 Exosome Diagnostics Lung Cancer Liquid Biops Product and Solutions

2.4.4 Exosome Diagnostics Lung Cancer Liquid Biops Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Exosome Diagnostics Recent Developments and Future Plans

2.5 F. Hoffmann-La Roche

2.5.1 F. Hoffmann-La Roche Details

2.5.2 F. Hoffmann-La Roche Major Business

2.5.3 F. Hoffmann-La Roche Lung Cancer Liquid Biops Product and Solutions

2.5.4 F. Hoffmann-La Roche Lung Cancer Liquid Biops Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 F. Hoffmann-La Roche Recent Developments and Future Plans

2.6 Clearbridge BioMedics

2.6.1 Clearbridge BioMedics Details

2.6.2 Clearbridge BioMedics Major Business

2.6.3 Clearbridge BioMedics Lung Cancer Liquid Biops Product and Solutions

2.6.4 Clearbridge BioMedics Lung Cancer Liquid Biops Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Clearbridge BioMedics Recent Developments and Future Plans

2.7 Bio-Rad Laboratories

2.7.1 Bio-Rad Laboratories Details

2.7.2 Bio-Rad Laboratories Major Business

2.7.3 Bio-Rad Laboratories Lung Cancer Liquid Biops Product and Solutions

2.7.4 Bio-Rad Laboratories Lung Cancer Liquid Biops Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Bio-Rad Laboratories Recent Developments and Future Plans

2.8 Agena Bioscience

2.8.1 Agena Bioscience Details

2.8.2 Agena Bioscience Major Business

2.8.3 Agena Bioscience Lung Cancer Liquid Biops Product and Solutions

2.8.4 Agena Bioscience Lung Cancer Liquid Biops Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Agena Bioscience Recent Developments and Future Plans

2.9 Cancer Genetics

2.9.1 Cancer Genetics Details

2.9.2 Cancer Genetics Major Business

2.9.3 Cancer Genetics Lung Cancer Liquid Biops Product and Solutions

2.9.4 Cancer Genetics Lung Cancer Liquid Biops Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Cancer Genetics Recent Developments and Future Plans

2.10 CellMax Life

2.10.1 CellMax Life Details

2.10.2 CellMax Life Major Business

2.10.3 CellMax Life Lung Cancer Liquid Biops Product and Solutions

2.10.4 CellMax Life Lung Cancer Liquid Biops Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 CellMax Life Recent Developments and Future Plans

2.11 Nateras

2.11.1 Nateras Details

2.11.2 Nateras Major Business

2.11.3 Nateras Lung Cancer Liquid Biops Product and Solutions

2.11.4 Nateras Lung Cancer Liquid Biops Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Nateras Recent Developments and Future Plans

2.12 MedGenome

2.12.1 MedGenome Details

2.12.2 MedGenome Major Business

2.12.3 MedGenome Lung Cancer Liquid Biops Product and Solutions

2.12.4 MedGenome Lung Cancer Liquid Biops Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 MedGenome Recent Developments and Future Plans

2.13 OncoDNA

2.13.1 OncoDNA Details

2.13.2 OncoDNA Major Business

2.13.3 OncoDNA Lung Cancer Liquid Biops Product and Solutions

2.13.4 OncoDNA Lung Cancer Liquid Biops Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 OncoDNA Recent Developments and Future Plans

2.14 Genomic Health

2.14.1 Genomic Health Details

2.14.2 Genomic Health Major Business

2.14.3 Genomic Health Lung Cancer Liquid Biops Product and Solutions

2.14.4 Genomic Health Lung Cancer Liquid Biops Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Genomic Health Recent Developments and Future Plans

2.15 Trovagene

2.15.1 Trovagene Details

2.15.2 Trovagene Major Business

2.15.3 Trovagene Lung Cancer Liquid Biops Product and Solutions

2.15.4 Trovagene Lung Cancer Liquid Biops Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Trovagene Recent Developments and Future Plans

2.16 Fluxion Biosciences

2.16.1 Fluxion Biosciences Details

2.16.2 Fluxion Biosciences Major Business

2.16.3 Fluxion Biosciences Lung Cancer Liquid Biops Product and Solutions

2.16.4 Fluxion Biosciences Lung Cancer Liquid Biops Revenue, Gross Margin and Market Share (2019-2021)

2.16.5 Fluxion Biosciences Recent Developments and Future Plans

2.17 Biodesix

2.17.1 Biodesix Details

2.17.2 Biodesix Major Business

2.17.3 Biodesix Lung Cancer Liquid Biops Product and Solutions

2.17.4 Biodesix Lung Cancer Liquid Biops Revenue, Gross Margin and Market Share (2019-2021)

2.17.5 Biodesix Recent Developments and Future Plans

2.18 Epic Sciences

2.18.1 Epic Sciences Details

2.18.2 Epic Sciences Major Business

2.18.3 Epic Sciences Lung Cancer Liquid Biops Product and Solutions

2.18.4 Epic Sciences Lung Cancer Liquid Biops Revenue, Gross Margin and Market Share (2019-2021)

2.18.5 Epic Sciences Recent Developments and Future Plans

2.19 Shuwen Biotech

2.19.1 Shuwen Biotech Details

2.19.2 Shuwen Biotech Major Business

2.19.3 Shuwen Biotech Lung Cancer Liquid Biops Product and Solutions

2.19.4 Shuwen Biotech Lung Cancer Liquid Biops Revenue, Gross Margin and Market Share (2019-2021)

2.19.5 Shuwen Biotech Recent Developments and Future Plans

2.20 Personal Genome Diagnostics

2.20.1 Personal Genome Diagnostics Details

2.20.2 Personal Genome Diagnostics Major Business

2.20.3 Personal Genome Diagnostics Lung Cancer Liquid Biops Product and Solutions

2.20.4 Personal Genome Diagnostics Lung Cancer Liquid Biops Revenue, Gross Margin and Market Share (2019-2021)

2.20.5 Personal Genome Diagnostics Recent Developments and Future Plans

2.21 Predicine

2.21.1 Predicine Details

2.21.2 Predicine Major Business

2.21.3 Predicine Lung Cancer Liquid Biops Product and Solutions

2.21.4 Predicine Lung Cancer Liquid Biops Revenue, Gross Margin and Market Share (2019-2021)

2.21.5 Predicine Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Lung Cancer Liquid Biops Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 5 Lung Cancer Liquid Biops Players Market Share

3.2.2 Top 10 Lung Cancer Liquid Biops Players Market Share

3.2.3 Market Competition Trend

3.3 Lung Cancer Liquid Biops Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Lung Cancer Liquid Biops Revenue and Market Share by Type (2016-2021)

4.2 Global Lung Cancer Liquid Biops Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Lung Cancer Liquid Biops Revenue Market Share by Application (2016-2021)

5.2 Lung Cancer Liquid Biops Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Lung Cancer Liquid Biops Revenue by Type (2016-2026)

6.2 North America Lung Cancer Liquid Biops Revenue by Application (2016-2026)

6.3 North America Lung Cancer Liquid Biops Market Size by Country

6.3.1 North America Lung Cancer Liquid Biops Revenue by Country (2016-2026)

6.3.2 United States Lung Cancer Liquid Biops Market Size and Forecast (2016-2026)

6.3.3 Canada Lung Cancer Liquid Biops Market Size and Forecast (2016-2026)

6.3.4 Mexico Lung Cancer Liquid Biops Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Lung Cancer Liquid Biops Revenue by Type (2016-2026)

7.2 Europe Lung Cancer Liquid Biops Revenue by Application (2016-2026)

7.3 Europe Lung Cancer Liquid Biops Market Size by Country

7.3.1 Europe Lung Cancer Liquid Biops Revenue by Country (2016-2026)

7.3.2 Germany Lung Cancer Liquid Biops Market Size and Forecast (2016-2026)

7.3.3 France Lung Cancer Liquid Biops Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Lung Cancer Liquid Biops Market Size and Forecast (2016-2026)

7.3.5 Russia Lung Cancer Liquid Biops Market Size and Forecast (2016-2026)

7.3.6 Italy Lung Cancer Liquid Biops Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Lung Cancer Liquid Biops Revenue by Type (2016-2026)

8.2 Asia-Pacific Lung Cancer Liquid Biops Revenue by Application (2016-2026)

8.3 Asia-Pacific Lung Cancer Liquid Biops Market Size by Region

8.3.1 Asia-Pacific Lung Cancer Liquid Biops Revenue by Region (2016-2026)

8.3.2 China Lung Cancer Liquid Biops Market Size and Forecast (2016-2026)

8.3.3 Japan Lung Cancer Liquid Biops Market Size and Forecast (2016-2026)

8.3.4 South Korea Lung Cancer Liquid Biops Market Size and Forecast (2016-2026)

8.3.5 India Lung Cancer Liquid Biops Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Lung Cancer Liquid Biops Market Size and Forecast (2016-2026)

8.3.7 Australia Lung Cancer Liquid Biops Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Lung Cancer Liquid Biops Revenue by Type (2016-2026)

9.2 South America Lung Cancer Liquid Biops Revenue by Application (2016-2026)

9.3 South America Lung Cancer Liquid Biops Market Size by Country

9.3.1 South America Lung Cancer Liquid Biops Revenue by Country (2016-2026)

9.3.2 Brazil Lung Cancer Liquid Biops Market Size and Forecast (2016-2026)

9.3.3 Argentina Lung Cancer Liquid Biops Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Lung Cancer Liquid Biops Revenue by Type (2016-2026)

10.2 Middle East & Africa Lung Cancer Liquid Biops Revenue by Application (2016-2026)

10.3 Middle East & Africa Lung Cancer Liquid Biops Market Size by Country

10.3.1 Middle East & Africa Lung Cancer Liquid Biops Revenue by Country (2016-2026)

10.3.2 Turkey Lung Cancer Liquid Biops Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Lung Cancer Liquid Biops Market Size and Forecast (2016-2026)

10.3.4 UAE Lung Cancer Liquid Biops Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Lung Cancer Liquid Biops Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Lung Cancer Liquid Biops Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Lung Cancer Liquid Biops Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Lung Cancer Liquid Biops Revenue (USD Million) by Region (2016-2021)

Table 5. Global Lung Cancer Liquid Biops Revenue Market Share by Region (2021-2026)

Table 6. Biocept Corporate Information, Head Office, and Major Competitors

Table 7. Biocept Major Business

Table 8. Biocept Lung Cancer Liquid Biops Product and Solutions

Table 9. Biocept Lung Cancer Liquid Biops Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. EntroGen Corporate Information, Head Office, and Major Competitors

Table 11. EntroGen Major Business

Table 12. EntroGen Lung Cancer Liquid Biops Product and Solutions

Table 13. EntroGen Lung Cancer Liquid Biops Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Cynvenio Biosystems Corporate Information, Head Office, and Major Competitors

Table 15. Cynvenio Biosystems Major Business

Table 16. Cynvenio Biosystems Lung Cancer Liquid Biops Product and Solutions

Table 17. Cynvenio Biosystems Lung Cancer Liquid Biops Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Exosome Diagnostics Corporate Information, Head Office, and Major Competitors

Table 19. Exosome Diagnostics Major Business

Table 20. Exosome Diagnostics Lung Cancer Liquid Biops Product and Solutions

Table 21. Exosome Diagnostics Lung Cancer Liquid Biops Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. F. Hoffmann-La Roche Corporate Information, Head Office, and Major Competitors

Table 23. F. Hoffmann-La Roche Major Business

Table 24. F. Hoffmann-La Roche Lung Cancer Liquid Biops Product and Solutions

Table 25. F. Hoffmann-La Roche Lung Cancer Liquid Biops Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Clearbridge BioMedics Corporate Information, Head Office, and Major Competitors

Table 27. Clearbridge BioMedics Major Business

Table 28. Clearbridge BioMedics Lung Cancer Liquid Biops Product and Solutions

Table 29. Clearbridge BioMedics Lung Cancer Liquid Biops Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors

Table 31. Bio-Rad Laboratories Major Business

Table 32. Bio-Rad Laboratories Lung Cancer Liquid Biops Product and Solutions

Table 33. Bio-Rad Laboratories Lung Cancer Liquid Biops Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Agena Bioscience Corporate Information, Head Office, and Major Competitors

Table 35. Agena Bioscience Major Business

Table 36. Agena Bioscience Lung Cancer Liquid Biops Product and Solutions

Table 37. Agena Bioscience Lung Cancer Liquid Biops Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Cancer Genetics Corporate Information, Head Office, and Major Competitors

Table 39. Cancer Genetics Major Business

Table 40. Cancer Genetics Lung Cancer Liquid Biops Product and Solutions

Table 41. Cancer Genetics Lung Cancer Liquid Biops Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. CellMax Life Corporate Information, Head Office, and Major Competitors

Table 43. CellMax Life Major Business

Table 44. CellMax Life Lung Cancer Liquid Biops Product and Solutions

Table 45. CellMax Life Lung Cancer Liquid Biops Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Nateras Corporate Information, Head Office, and Major Competitors

Table 47. Nateras Major Business

Table 48. Nateras Lung Cancer Liquid Biops Product and Solutions

Table 49. Nateras Lung Cancer Liquid Biops Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. MedGenome Corporate Information, Head Office, and Major Competitors

Table 51. MedGenome Major Business

Table 52. MedGenome Lung Cancer Liquid Biops Product and Solutions

Table 53. MedGenome Lung Cancer Liquid Biops Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. OncoDNA Corporate Information, Head Office, and Major Competitors

Table 55. OncoDNA Major Business

Table 56. OncoDNA Lung Cancer Liquid Biops Product and Solutions

Table 57. OncoDNA Lung Cancer Liquid Biops Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Genomic Health Corporate Information, Head Office, and Major Competitors

Table 59. Genomic Health Major Business

Table 60. Genomic Health Lung Cancer Liquid Biops Product and Solutions

Table 61. Genomic Health Lung Cancer Liquid Biops Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Trovagene Corporate Information, Head Office, and Major Competitors

Table 63. Trovagene Major Business

Table 64. Trovagene Lung Cancer Liquid Biops Product and Solutions

Table 65. Trovagene Lung Cancer Liquid Biops Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Fluxion Biosciences Corporate Information, Head Office, and Major Competitors

Table 67. Fluxion Biosciences Major Business

Table 68. Fluxion Biosciences Lung Cancer Liquid Biops Product and Solutions

Table 69. Fluxion Biosciences Lung Cancer Liquid Biops Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 70. Biodesix Corporate Information, Head Office, and Major Competitors

Table 71. Biodesix Major Business

Table 72. Biodesix Lung Cancer Liquid Biops Product and Solutions

Table 73. Biodesix Lung Cancer Liquid Biops Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 74. Epic Sciences Corporate Information, Head Office, and Major Competitors

Table 75. Epic Sciences Major Business

Table 76. Epic Sciences Lung Cancer Liquid Biops Product and Solutions

Table 77. Epic Sciences Lung Cancer Liquid Biops Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 78. Shuwen Biotech Corporate Information, Head Office, and Major Competitors

Table 79. Shuwen Biotech Major Business

Table 80. Shuwen Biotech Lung Cancer Liquid Biops Product and Solutions

Table 81. Shuwen Biotech Lung Cancer Liquid Biops Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 82. Personal Genome Diagnostics Corporate Information, Head Office, and Major Competitors

Table 83. Personal Genome Diagnostics Major Business

Table 84. Personal Genome Diagnostics Lung Cancer Liquid Biops Product and Solutions

Table 85. Personal Genome Diagnostics Lung Cancer Liquid Biops Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 86. Predicine Corporate Information, Head Office, and Major Competitors

Table 87. Predicine Major Business

Table 88. Predicine Lung Cancer Liquid Biops Product and Solutions

Table 89. Predicine Lung Cancer Liquid Biops Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 90. Global Lung Cancer Liquid Biops Revenue (USD Million) by Players (2019-2021)

Table 91. Global Lung Cancer Liquid Biops Revenue Share by Players (2019-2021)

Table 92. Breakdown of Lung Cancer Liquid Biops by Company Type (Tier 1, Tier 2 and Tier 3)

Table 93. Lung Cancer Liquid Biops Players Head Office, Products and Services Provided

Table 94. Lung Cancer Liquid Biops Mergers & Acquisitions in the Past Five Years

Table 95. Lung Cancer Liquid Biops New Entrants and Expansion Plans

Table 96. Global Lung Cancer Liquid Biops Revenue (USD Million) by Type (2016-2021)

Table 97. Global Lung Cancer Liquid Biops Revenue Share by Type (2016-2021)

Table 98. Global Lung Cancer Liquid Biops Revenue Forecast by Type (2021-2026)

Table 99. Global Lung Cancer Liquid Biops Revenue by Application (2016-2021)

Table 100. Global Lung Cancer Liquid Biops Revenue Forecast by Application (2021-2026)

Table 101. North America Lung Cancer Liquid Biops Revenue by Type (2016-2021) & (USD Million)

Table 102. North America Lung Cancer Liquid Biops Revenue by Type (2021-2026) & (USD Million)

Table 103. North America Lung Cancer Liquid Biops Revenue by Application (2016-2021) & (USD Million)

Table 104. North America Lung Cancer Liquid Biops Revenue by Application (2021-2026) & (USD Million)

Table 105. North America Lung Cancer Liquid Biops Revenue by Country (2016-2021) & (USD Million)

Table 106. North America Lung Cancer Liquid Biops Revenue by Country (2021-2026) & (USD Million)

Table 107. Europe Lung Cancer Liquid Biops Revenue by Type (2016-2021) & (USD Million)

Table 108. Europe Lung Cancer Liquid Biops Revenue by Type (2021-2026) & (USD Million)

Table 109. Europe Lung Cancer Liquid Biops Revenue by Application (2016-2021) & (USD Million)

Table 110. Europe Lung Cancer Liquid Biops Revenue by Application (2021-2026) & (USD Million)

Table 111. Europe Lung Cancer Liquid Biops Revenue by Country (2016-2021) & (USD Million)

Table 112. Europe Lung Cancer Liquid Biops Revenue by Country (2021-2026) & (USD Million)

Table 113. Asia-Pacific Lung Cancer Liquid Biops Revenue by Type (2016-2021) & (USD Million)

Table 114. Asia-Pacific Lung Cancer Liquid Biops Revenue by Type (2021-2026) & (USD Million)

Table 115. Asia-Pacific Lung Cancer Liquid Biops Revenue by Application (2016-2021) & (USD Million)

Table 116. Asia-Pacific Lung Cancer Liquid Biops Revenue by Application (2021-2026) & (USD Million)

Table 117. Asia-Pacific Lung Cancer Liquid Biops Revenue by Region (2016-2021) & (USD Million)

Table 118. Asia-Pacific Lung Cancer Liquid Biops Revenue by Region (2021-2026) & (USD Million)

Table 119. South America Lung Cancer Liquid Biops Revenue by Type (2016-2021) & (USD Million)

Table 120. South America Lung Cancer Liquid Biops Revenue by Type (2021-2026) & (USD Million)

Table 121. South America Lung Cancer Liquid Biops Revenue by Application (2016-2021) & (USD Million)

Table 122. South America Lung Cancer Liquid Biops Revenue by Application (2021-2026) & (USD Million)

Table 123. South America Lung Cancer Liquid Biops Revenue by Country (2016-2021) & (USD Million)

Table 124. South America Lung Cancer Liquid Biops Revenue by Country (2021-2026) & (USD Million)

Table 125. Middle East & Africa Lung Cancer Liquid Biops Revenue by Type (2016-2021) & (USD Million)

Table 126. Middle East & Africa Lung Cancer Liquid Biops Revenue by Type (2021-2026) & (USD Million)

Table 127. Middle East & Africa Lung Cancer Liquid Biops Revenue by Application (2016-2021) & (USD Million)

Table 128. Middle East & Africa Lung Cancer Liquid Biops Revenue by Application (2021-2026) & (USD Million)

Table 129. Middle East & Africa Lung Cancer Liquid Biops Revenue by Country (2016-2021) & (USD Million)

Table 130. Middle East & Africa Lung Cancer Liquid Biops Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Lung Cancer Liquid Biops Picture

Figure 2. Global Lung Cancer Liquid Biops Revenue Market Share by Type in 2020

Figure 3. Exosomes and RNA

Figure 4. CTCs and ctDNA

Figure 5. Lung Cancer Liquid Biops Revenue Market Share by Application in 2020

Figure 6. Hospitals and Clinics Picture

Figure 7. Physicians'office Laboratories Picture

Figure 8. Clinical Diagnostic Laboratories Picture

Figure 9. Global Lung Cancer Liquid Biops Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 10. Global Lung Cancer Liquid Biops Revenue and Forecast (2016-2026) & (USD Million)

Figure 11. Global Lung Cancer Liquid Biops Revenue Market Share by Region (2016-2026)

Figure 12. Global Lung Cancer Liquid Biops Revenue Market Share by Region in 2020

Figure 13. North America Lung Cancer Liquid Biops Revenue (USD Million) and Growth Rate (2016-2026)

Figure 14. Europe Lung Cancer Liquid Biops Revenue (USD Million) and Growth Rate (2016-2026)

Figure 15. Asia-Pacific Lung Cancer Liquid Biops Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. South America Lung Cancer Liquid Biops Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Lung Cancer Liquid Biops Market Drivers

Figure 18. Lung Cancer Liquid Biops Market Restraints

Figure 19. Lung Cancer Liquid Biops Market Trends

Figure 20. Biocept Recent Developments and Future Plans

Figure 21. EntroGen Recent Developments and Future Plans

Figure 22. Cynvenio Biosystems Recent Developments and Future Plans

Figure 23. Exosome Diagnostics Recent Developments and Future Plans

Figure 24. F. Hoffmann-La Roche Recent Developments and Future Plans

Figure 25. Clearbridge BioMedics Recent Developments and Future Plans

Figure 26. Bio-Rad Laboratories Recent Developments and Future Plans

Figure 27. Agena Bioscience Recent Developments and Future Plans

Figure 28. Cancer Genetics Recent Developments and Future Plans

Figure 29. CellMax Life Recent Developments and Future Plans

Figure 30. Nateras Recent Developments and Future Plans

Figure 31. MedGenome Recent Developments and Future Plans

Figure 32. OncoDNA Recent Developments and Future Plans

Figure 33. Genomic Health Recent Developments and Future Plans

Figure 34. Trovagene Recent Developments and Future Plans

Figure 35. Fluxion Biosciences Recent Developments and Future Plans

Figure 36. Biodesix Recent Developments and Future Plans

Figure 37. Epic Sciences Recent Developments and Future Plans

Figure 38. Shuwen Biotech Recent Developments and Future Plans

Figure 39. Personal Genome Diagnostics Recent Developments and Future Plans

Figure 40. Predicine Recent Developments and Future Plans

Figure 42. Global Lung Cancer Liquid Biops Revenue Share by Players in 2020

Figure 43. Lung Cancer Liquid Biops Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 44. Global Top 3 Players Lung Cancer Liquid Biops Revenue Market Share in 2020

Figure 45. Global Top 10 Players Lung Cancer Liquid Biops Revenue Market Share in 2020

Figure 46. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 47. Global Lung Cancer Liquid Biops Revenue Share by Type in 2020

Figure 48. Global Lung Cancer Liquid Biops Market Share Forecast by Type (2021-2026)

Figure 49. Global Lung Cancer Liquid Biops Revenue Share by Application in 2020

Figure 50. Global Lung Cancer Liquid Biops Market Share Forecast by Application (2021-2026)

Figure 51. North America Lung Cancer Liquid Biops Sales Market Share by Type (2016-2026)

Figure 52. North America Lung Cancer Liquid Biops Sales Market Share by Application (2016-2026)

Figure 53. North America Lung Cancer Liquid Biops Revenue Market Share by Country (2016-2026)

Figure 54. United States Lung Cancer Liquid Biops Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. Canada Lung Cancer Liquid Biops Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Mexico Lung Cancer Liquid Biops Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Europe Lung Cancer Liquid Biops Sales Market Share by Type (2016-2026)

Figure 58. Europe Lung Cancer Liquid Biops Sales Market Share by Application (2016-2026)

Figure 59. Europe Lung Cancer Liquid Biops Revenue Market Share by Country (2016-2026)

Figure 60. Germany Lung Cancer Liquid Biops Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. France Lung Cancer Liquid Biops Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. United Kingdom Lung Cancer Liquid Biops Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Russia Lung Cancer Liquid Biops Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Italy Lung Cancer Liquid Biops Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. Asia-Pacific Lung Cancer Liquid Biops Sales Market Share by Type (2016-2026)

Figure 66. Asia-Pacific Lung Cancer Liquid Biops Sales Market Share by Application (2016-2026)

Figure 67. Asia-Pacific Lung Cancer Liquid Biops Revenue Market Share by Region (2016-2026)

Figure 68. China Lung Cancer Liquid Biops Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Japan Lung Cancer Liquid Biops Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. South Korea Lung Cancer Liquid Biops Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. India Lung Cancer Liquid Biops Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Southeast Asia Lung Cancer Liquid Biops Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Australia Lung Cancer Liquid Biops Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. South America Lung Cancer Liquid Biops Sales Market Share by Type (2016-2026)

Figure 75. South America Lung Cancer Liquid Biops Sales Market Share by Application (2016-2026)

Figure 76. South America Lung Cancer Liquid Biops Revenue Market Share by Country (2016-2026)

Figure 77. Brazil Lung Cancer Liquid Biops Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. Argentina Lung Cancer Liquid Biops Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. Middle East and Africa Lung Cancer Liquid Biops Sales Market Share by Type (2016-2026)

Figure 80. Middle East and Africa Lung Cancer Liquid Biops Sales Market Share by Application (2016-2026)

Figure 81. Middle East and Africa Lung Cancer Liquid Biops Revenue Market Share by Country (2016-2026)

Figure 82. Turkey Lung Cancer Liquid Biops Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 83. Saudi Arabia Lung Cancer Liquid Biops Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 84. UAE Lung Cancer Liquid Biops Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 85. Methodology

Figure 86. Research Process and Data Source